Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.

The efficacy of Sinemet CR4 (50/200) was compared to standard Sinemet (25/100) in an open label crossover study in 22 patients with Parkinson's disease. All patients experienced end of dose failure and 11 had dyskinesia. Unified Parkinson's disease, Hoehn and Yahr, Schwab and England score...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Factor, S A, Sanchez-Ramos, J R, Weiner, W J, Ingenito, A M
Format: Artigo
Langue:Inglês
Publié: 1989
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1032662/
https://ncbi.nlm.nih.gov/pubmed/2709040
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires